SERTRALINE HYDROCHLORIDE

SERTRALINE HYDROCHLORIDE was reported 119291 times

These side effects are most commonly reported by patients taking SERTRALINE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 8290
1 NAUSEA 8257
2 FATIGUE 7759
3 HEADACHE 6885
4 ANXIETY 6495
5 DEPRESSION 6372
6 DIARRHOEA 5764
7 DIZZINESS 5569
8 PAIN 5517
9 DYSPNOEA 4945
10 INSOMNIA 4510
11 VOMITING 4502
12 FALL 4295
13 ASTHENIA 4237
14 OFF LABEL USE 4162
15 MALAISE 3717
16 FEELING ABNORMAL 3438
17 ARTHRALGIA 3274
18 WEIGHT INCREASED 3160
19 TREMOR 2963
20 SOMNOLENCE 2958
21 WEIGHT DECREASED 2954
22 CONDITION AGGRAVATED 2845
23 SUICIDAL IDEATION 2800
24 DRUG INTERACTION 2767
25 PRURITUS 2710
26 PNEUMONIA 2660
27 DRUG HYPERSENSITIVITY 2593
28 RASH 2558
29 PAIN IN EXTREMITY 2540
30 DEATH 2524
31 COUGH 2459
32 BACK PAIN 2380
33 DECREASED APPETITE 2319
34 HYPERTENSION 2292
35 CONFUSIONAL STATE 2289
36 ABDOMINAL PAIN 2259
37 PYREXIA 2218
38 CHEST PAIN 2073
39 CONSTIPATION 1995
40 GAIT DISTURBANCE 1899
41 ABDOMINAL PAIN UPPER 1890
42 URINARY TRACT INFECTION 1850
43 SUICIDE ATTEMPT 1798
44 HYPERHIDROSIS 1785
45 MUSCLE SPASMS 1768
46 PARAESTHESIA 1763
47 HYPOTENSION 1720
48 MEMORY IMPAIRMENT 1718
49 MYALGIA 1682
50 PRODUCT DOSE OMISSION ISSUE 1633
51 HYPOAESTHESIA 1619
52 BLOOD PRESSURE INCREASED 1545
53 LOSS OF CONSCIOUSNESS 1532
54 ABDOMINAL DISCOMFORT 1531
55 ANAEMIA 1525
56 VISION BLURRED 1521
57 AGITATION 1504
58 OVERDOSE 1488
59 ALOPECIA 1483
60 MATERNAL EXPOSURE DURING PREGNANCY 1478
61 DEHYDRATION 1436
62 OEDEMA PERIPHERAL 1408
63 PRODUCT USE IN UNAPPROVED INDICATION 1394
64 DIABETES MELLITUS 1389
65 HYPERSENSITIVITY 1368
66 INJECTION SITE PAIN 1347
67 PALPITATIONS 1329
68 NASOPHARYNGITIS 1306
69 HALLUCINATION 1299
70 TOXICITY TO VARIOUS AGENTS 1263
71 IRRITABILITY 1259
72 MYOCARDIAL INFARCTION 1222
73 BALANCE DISORDER 1221
74 GASTROOESOPHAGEAL REFLUX DISEASE 1218
75 CHILLS 1217
76 COMPLETED SUICIDE 1215
77 INTENTIONAL OVERDOSE 1212
78 RENAL FAILURE 1207
79 CEREBROVASCULAR ACCIDENT 1204
80 SYNCOPE 1204
81 MIGRAINE 1198
82 DISTURBANCE IN ATTENTION 1197
83 ERYTHEMA 1177
84 CONTUSION 1174
85 SINUSITIS 1174
86 PULMONARY EMBOLISM 1134
87 ASTHMA 1132
88 AGGRESSION 1127
89 AMNESIA 1093
90 PANIC ATTACK 1087
91 EMOTIONAL DISTRESS 1078
92 DRUG DOSE OMISSION 1068
93 COVID-19 1057
94 NERVOUSNESS 1049
95 DEPRESSED MOOD 1045
96 MUSCULAR WEAKNESS 1043
97 DYSPHAGIA 1041
98 DYSPEPSIA 1038
99 HEART RATE INCREASED 1033
100 DRY MOUTH 1021
101 INJURY 1020
102 TACHYCARDIA 1012
103 CRYING 1011
104 CONVULSION 1007
105 URTICARIA 1004
106 STRESS 1002
107 DRUG ABUSE 976
108 BLOOD GLUCOSE INCREASED 972
109 BLOOD CHOLESTEROL INCREASED 968
110 PRODUCT USE ISSUE 965
111 SEROTONIN SYNDROME 949
112 CHEST DISCOMFORT 948
113 PERIPHERAL SWELLING 938
114 SEIZURE 937
115 SLEEP DISORDER 937
116 INCORRECT DOSE ADMINISTERED 923
117 TYPE 2 DIABETES MELLITUS 913
118 ACUTE KIDNEY INJURY 911
119 ABNORMAL BEHAVIOUR 909
120 DRUG WITHDRAWAL SYNDROME 908
121 VERTIGO 898
122 VISUAL IMPAIRMENT 891
123 INFECTION 889
124 BRONCHITIS 880
125 RESTLESSNESS 869
126 CHRONIC KIDNEY DISEASE 864
127 INFLUENZA 864
128 MUSCULOSKELETAL STIFFNESS 864
129 ABDOMINAL DISTENSION 861
130 FLUSHING 859
131 CARDIAC FAILURE CONGESTIVE 857
132 SEPSIS 856
133 OROPHARYNGEAL PAIN 848
134 WITHDRAWAL SYNDROME 843
135 DRUG INTOLERANCE 842
136 ANGER 836
137 HYPONATRAEMIA 827
138 MENTAL DISORDER 826
139 INFLUENZA LIKE ILLNESS 812
140 JOINT SWELLING 798
141 HAEMOGLOBIN DECREASED 791
142 TINNITUS 783
143 ATRIAL FIBRILLATION 778
144 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 752
145 ARTHRITIS 751
146 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 746
147 ILLNESS 745
148 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 737
149 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 736
150 DYSKINESIA 732
151 SPEECH DISORDER 732
152 WHEEZING 731
153 DEEP VEIN THROMBOSIS 727
154 EYE PAIN 725
155 CARDIAC DISORDER 721
156 LETHARGY 721
157 TREATMENT NONCOMPLIANCE 719
158 CARDIAC ARREST 704
159 NEUROPATHY PERIPHERAL 697
160 PSYCHOTIC DISORDER 696
161 PRODUCT QUALITY ISSUE 689
162 NIGHTMARE 688
163 GENERAL PHYSICAL HEALTH DETERIORATION 682
164 SWELLING 682
165 WHITE BLOOD CELL COUNT DECREASED 682
166 THROMBOSIS 679
167 DRY SKIN 676
168 NECK PAIN 675
169 DRUG EXPOSURE DURING PREGNANCY 663
170 DRUG DEPENDENCE 662
171 PRODUCTIVE COUGH 658
172 COMA 652
173 FOETAL EXPOSURE DURING PREGNANCY 652
174 DISORIENTATION 651
175 INTENTIONAL SELF-INJURY 651
176 BURNING SENSATION 647
177 SWELLING FACE 646
178 GASTROINTESTINAL DISORDER 645
179 PLATELET COUNT DECREASED 639
180 DYSPHONIA 636
181 DYSGEUSIA 634
182 NO ADVERSE EVENT 630
183 HOT FLUSH 629
184 HOSPITALISATION 625
185 RHEUMATOID ARTHRITIS 621
186 PSORIASIS 617
187 PANCREATITIS 612
188 EPISTAXIS 610
189 UNEVALUABLE EVENT 609
190 EMOTIONAL DISORDER 607
191 COGNITIVE DISORDER 599
192 INTENTIONAL PRODUCT USE ISSUE 589
193 APATHY 585
194 PRODUCT SUBSTITUTION ISSUE 585
195 UPPER RESPIRATORY TRACT INFECTION 584
196 GASTROINTESTINAL HAEMORRHAGE 578
197 PARANOIA 574
198 OSTEOARTHRITIS 571
199 INJECTION SITE ERYTHEMA 567
200 MOOD SWINGS 566
201 FEELING HOT 565
202 THROMBOCYTOPENIA 563
203 RHINORRHOEA 561
204 BLOOD PRESSURE DECREASED 557
205 FEAR 551
206 NASAL CONGESTION 551
207 ROAD TRAFFIC ACCIDENT 551
208 RESPIRATORY FAILURE 549
209 MATERNAL EXPOSURE TIMING UNSPECIFIED 548
210 MULTIPLE SCLEROSIS RELAPSE 543
211 INTENTIONAL PRODUCT MISUSE 538
212 HYPOTHYROIDISM 535
213 HYPOKALAEMIA 532
214 HEPATIC ENZYME INCREASED 531
215 ATRIAL SEPTAL DEFECT 528
216 CELLULITIS 524
217 MOBILITY DECREASED 523
218 OXYGEN SATURATION DECREASED 523
219 ALANINE AMINOTRANSFERASE INCREASED 522
220 OBESITY 520
221 THINKING ABNORMAL 517
222 SLEEP APNOEA SYNDROME 513
223 URINARY INCONTINENCE 510
224 HYPERSOMNIA 509
225 DYSARTHRIA 506
226 HAEMORRHAGE 506
227 MANIA 506
228 ABNORMAL DREAMS 505
229 HALLUCINATION, AUDITORY 504
230 NEPHROLITHIASIS 498
231 DRUG EFFECT DECREASED 496
232 NIGHT SWEATS 496
233 CHOLELITHIASIS 495
234 ARTHROPATHY 487
235 FLATULENCE 485
236 STAPHYLOCOCCAL INFECTION 481
237 SWOLLEN TONGUE 478
238 THERAPEUTIC RESPONSE UNEXPECTED 478
239 CARDIO-RESPIRATORY ARREST 477
240 MUSCULOSKELETAL PAIN 475
241 NEUTROPENIA 471
242 ASPARTATE AMINOTRANSFERASE INCREASED 470
243 CONGENITAL ANOMALY 470
244 HEAD INJURY 469
245 PRESYNCOPE 469
246 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 467
247 MUSCLE TWITCHING 466
248 ANHEDONIA 465
249 OEDEMA 463
250 RENAL FAILURE ACUTE 459
251 FLUID RETENTION 457
252 SURGERY 454
253 HYPERGLYCAEMIA 452
254 RASH PRURITIC 449
255 BONE PAIN 446
256 BLOOD CREATININE INCREASED 442
257 ADVERSE EVENT 441
258 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 439
259 PREMATURE BABY 439
260 SEDATION 435
261 PHOTOPHOBIA 434
262 PULMONARY OEDEMA 434
263 OSTEOPOROSIS 429
264 ADVERSE DRUG REACTION 426
265 RECTAL HAEMORRHAGE 426
266 DISEASE PROGRESSION 425
267 DIPLOPIA 423
268 CORONARY ARTERY DISEASE 420
269 FIBROMYALGIA 418
270 CATARACT 417
271 SEXUAL DYSFUNCTION 417
272 PLEURAL EFFUSION 416
273 ERECTILE DYSFUNCTION 415
274 MOOD ALTERED 415
275 SKIN EXFOLIATION 414
276 MENTAL STATUS CHANGES 413
277 POLLAKIURIA 411
278 TARDIVE DYSKINESIA 410
279 RESTLESS LEGS SYNDROME 406
280 HYPERLIPIDAEMIA 403
281 WRONG TECHNIQUE IN DRUG USAGE PROCESS 402
282 HYPOGLYCAEMIA 401
283 ACTIVITIES OF DAILY LIVING IMPAIRED 400
284 HALLUCINATION, VISUAL 399
285 DISCOMFORT 396
286 BRADYCARDIA 395
287 CARDIAC FAILURE 395
288 ELECTROCARDIOGRAM QT PROLONGED 395
289 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 393
290 DRY EYE 393
291 MENTAL IMPAIRMENT 393
292 BLINDNESS 391
293 HERPES ZOSTER 391
294 HAEMATEMESIS 389
295 EXPOSURE DURING PREGNANCY 387
296 HYPOXIA 387
297 DYSPNOEA EXERTIONAL 386
298 LUNG DISORDER 386
299 MULTIPLE SCLEROSIS 386
300 THROAT IRRITATION 386
301 DYSURIA 385
302 ARRHYTHMIA 384
303 INFUSION RELATED REACTION 382
304 BIPOLAR DISORDER 378
305 HAEMATOCHEZIA 378
306 STOMATITIS 377
307 URINARY RETENTION 377
308 BLOOD POTASSIUM DECREASED 374
309 RHABDOMYOLYSIS 369
310 BLOOD TRIGLYCERIDES INCREASED 368
311 DEPRESSED LEVEL OF CONSCIOUSNESS 368
312 ECONOMIC PROBLEM 368
313 VENTRICULAR SEPTAL DEFECT 368
314 PRODUCT DOSE OMISSION 367
315 HEAD DISCOMFORT 366
316 THERAPEUTIC RESPONSE DECREASED 366
317 ALTERED STATE OF CONSCIOUSNESS 365
318 RENAL DISORDER 365
319 HAEMATURIA 360
320 FEELING JITTERY 359
321 DECREASED INTEREST 358
322 MEDICATION ERROR 357
323 RENAL IMPAIRMENT 357
324 OBSESSIVE-COMPULSIVE DISORDER 356
325 INJECTION SITE BRUISING 355
326 PULMONARY FIBROSIS 352
327 WHITE BLOOD CELL COUNT INCREASED 351
328 BLISTER 350
329 DELUSION 348
330 SKIN DISCOLOURATION 348
331 DISEASE RECURRENCE 346
332 RESPIRATORY ARREST 344
333 GASTRITIS 343
334 APHASIA 342
335 PAIN IN JAW 342
336 MOVEMENT DISORDER 341
337 DELIRIUM 339
338 INFLAMMATION 339
339 TRANSIENT ISCHAEMIC ATTACK 339
340 ANAPHYLACTIC REACTION 338
341 DEVICE ISSUE 337
342 INTERVERTEBRAL DISC PROTRUSION 337
343 INJECTION SITE SWELLING 336
344 VIRAL INFECTION 336
345 DEMENTIA 335
346 THERAPY CESSATION 335
347 ANGIOEDEMA 333
348 INJECTION SITE REACTION 333
349 AKATHISIA 332
350 MIDDLE INSOMNIA 328
351 SOPOR 328
352 DEVICE DISLOCATION 325
353 ANGINA PECTORIS 323
354 HEART RATE DECREASED 323
355 CYSTITIS 321
356 ILL-DEFINED DISORDER 321
357 INJECTION SITE PRURITUS 321
358 PSYCHIATRIC SYMPTOM 320
359 UNRESPONSIVE TO STIMULI 320
360 WOUND 315
361 PHARMACEUTICAL PRODUCT COMPLAINT 314
362 HAEMOPTYSIS 312
363 DYSSTASIA 311
364 MAJOR DEPRESSION 310
365 PATENT DUCTUS ARTERIOSUS 310
366 ABORTION SPONTANEOUS 309
367 ASCITES 307
368 HAEMATOCRIT DECREASED 307
369 BLOOD GLUCOSE DECREASED 306
370 THERAPY INTERRUPTED 306
371 VAGINAL HAEMORRHAGE 306
372 GASTRIC DISORDER 305
373 IMPAIRED WORK ABILITY 305
374 BLOOD CREATINE PHOSPHOKINASE INCREASED 304
375 HIP FRACTURE 304
376 GALLBLADDER DISORDER 303
377 BREAST CANCER 301
378 NERVOUS SYSTEM DISORDER 300
379 HAEMORRHOIDS 299
380 INJECTION SITE HAEMORRHAGE 297
381 PRESCRIBED OVERDOSE 297
382 CARDIOMEGALY 295
383 HEPATIC STEATOSIS 294
384 CROHN^S DISEASE 291
385 TENSION 291
386 EATING DISORDER 290
387 INTERNATIONAL NORMALISED RATIO INCREASED 290
388 POOR QUALITY SLEEP 289
389 SKIN BURNING SENSATION 283
390 COORDINATION ABNORMAL 282
391 DEVICE EXPULSION 282
392 IMPAIRED HEALING 282
393 OCULAR HYPERAEMIA 281
394 DIABETES MELLITUS INADEQUATE CONTROL 279
395 LIBIDO DECREASED 279
396 PSYCHOMOTOR HYPERACTIVITY 277
397 CHOLECYSTITIS CHRONIC 276
398 RIB FRACTURE 276
399 SKIN DISORDER 273
400 RED BLOOD CELL COUNT DECREASED 272
401 FEELING COLD 271
402 ACNE 270
403 HEART RATE IRREGULAR 269
404 LIMB INJURY 269
405 END STAGE RENAL DISEASE 268
406 TRICUSPID VALVE INCOMPETENCE 267
407 UNDERDOSE 266
408 EPILEPSY 265
409 PULMONARY HYPERTENSION 265
410 ANOREXIA 264
411 DYSTONIA 264
412 RESPIRATORY DISTRESS 264
413 EAR PAIN 263
414 FOOT FRACTURE 263
415 RETCHING 262
416 JOINT INJURY 260
417 DEAFNESS 259
418 HEART DISEASE CONGENITAL 259
419 POST-TRAUMATIC STRESS DISORDER 259
420 BLOOD SODIUM DECREASED 258
421 EXTRAPYRAMIDAL DISORDER 258
422 ORAL PAIN 258
423 ABASIA 257
424 APPETITE DISORDER 257
425 COLITIS 257
426 ECZEMA 257
427 MITRAL VALVE INCOMPETENCE 257
428 CARPAL TUNNEL SYNDROME 256
429 EYE DISORDER 256
430 MYDRIASIS 256
431 EYE SWELLING 255
432 MUSCLE TIGHTNESS 255
433 NEOPLASM MALIGNANT 254
434 HYPOACUSIS 252
435 ORTHOSTATIC HYPOTENSION 252
436 PNEUMONIA ASPIRATION 251
437 PANCYTOPENIA 250
438 IRRITABLE BOWEL SYNDROME 249
439 EAR INFECTION 248
440 OCULAR DISCOMFORT 248
441 SINUS DISORDER 248
442 BRUXISM 246
443 CARDIAC MURMUR 246
444 FUNGAL INFECTION 245
445 NEUROLEPTIC MALIGNANT SYNDROME 245
446 PRE-EXISTING CONDITION IMPROVED 245
447 RENAL INJURY 245
448 MALIGNANT NEOPLASM PROGRESSION 244
449 INTESTINAL OBSTRUCTION 242
450 DIABETIC KETOACIDOSIS 240
451 EYE IRRITATION 240
452 DEVICE MALFUNCTION 239
453 INCREASED APPETITE 238
454 SEASONAL ALLERGY 237
455 BLOOD ALKALINE PHOSPHATASE INCREASED 236
456 SKIN ULCER 236
457 LIVER DISORDER 235
458 ACCIDENTAL OVERDOSE 233
459 DERMATITIS ATOPIC 233
460 HALLUCINATIONS, MIXED 233
461 RESPIRATORY DISORDER 233
462 PERSONALITY CHANGE 232
463 ACUTE MYOCARDIAL INFARCTION 231
464 DRUG EFFECT INCOMPLETE 231
465 HAEMORRHAGIC STROKE 231
466 THROAT TIGHTNESS 231
467 PANCREATITIS ACUTE 230
468 PREGNANCY 230
469 FEMUR FRACTURE 229
470 GASTROENTERITIS VIRAL 229
471 LYMPHADENOPATHY 229
472 HIATUS HERNIA 228
473 HOMICIDAL IDEATION 228
474 NEURALGIA 228
475 RASH ERYTHEMATOUS 228
476 HYPERKALAEMIA 227
477 LIVER FUNCTION TEST ABNORMAL 227
478 VISUAL ACUITY REDUCED 226
479 COLD SWEAT 225
480 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 225
481 GENERALISED OEDEMA 224
482 DENTAL CARIES 223
483 GYNAECOMASTIA 222
484 JOINT STIFFNESS 222
485 BLOOD PRESSURE FLUCTUATION 220
486 BONE DISORDER 220
487 DRUG TOXICITY 220
488 HAEMATOMA 219
489 NEGATIVE THOUGHTS 218
490 SCAR 218
491 GRAND MAL CONVULSION 217
492 HYPOPHAGIA 216
493 PALLOR 216
494 INTERVERTEBRAL DISC DEGENERATION 215
495 ARTERIOSCLEROSIS 213
496 CEREBRAL HAEMORRHAGE 213
497 INTERSTITIAL LUNG DISEASE 213
498 OSTEOPENIA 213
499 THERAPEUTIC PRODUCT EFFECT DECREASED 213
500 COLITIS ULCERATIVE 212
501 DIVERTICULITIS 212
502 RASH MACULAR 212
503 C-REACTIVE PROTEIN INCREASED 211
504 SEPTIC SHOCK 210
505 TOOTH DISORDER 210
506 UPPER LIMB FRACTURE 210
507 ANKLE FRACTURE 209
508 RESPIRATORY TRACT INFECTION 209
509 HEPATITIS 208
510 TOOTHACHE 208
511 MENORRHAGIA 207
512 AFFECTIVE DISORDER 206
513 DIABETIC NEUROPATHY 206
514 KIDNEY INFECTION 206
515 PELVIC PAIN 206
516 ATELECTASIS 205
517 FULL BLOOD COUNT ABNORMAL 205
518 OBSTRUCTIVE AIRWAYS DISORDER 205
519 SENSORY DISTURBANCE 205
520 GASTRIC ULCER 204
521 LIMB DISCOMFORT 204
522 MENSTRUATION IRREGULAR 203
523 THERAPY NON-RESPONDER 203
524 FEELING GUILTY 202
525 DRUG SCREEN POSITIVE 201
526 THERMAL BURN 200
527 PRODUCT DOSE OMISSION IN ERROR 199
528 FEBRILE NEUTROPENIA 198
529 FEELINGS OF WORTHLESSNESS 198
530 MATERNAL DRUGS AFFECTING FOETUS 198
531 MUSCLE RIGIDITY 198
532 PARKINSON^S DISEASE 198
533 EOSINOPHILIA 197
534 PRESCRIBED UNDERDOSE 197
535 SKIN LESION 197
536 SNEEZING 197
537 TREATMENT FAILURE 197
538 GAIT INABILITY 196
539 LEUKOPENIA 194
540 MYOCLONUS 194
541 TALIPES 194
542 ACUTE RESPIRATORY FAILURE 193
543 INTENTIONAL DOSE OMISSION 193
544 LOWER RESPIRATORY TRACT INFECTION 193
545 PROCEDURAL PAIN 193
546 BLOOD PRESSURE SYSTOLIC INCREASED 191
547 EUPHORIC MOOD 191
548 METRORRHAGIA 191
549 PARKINSONISM 191
550 ULCER 191
551 BODY TEMPERATURE INCREASED 190
552 FREQUENT BOWEL MOVEMENTS 190
553 ACCIDENTAL EXPOSURE TO PRODUCT 189
554 SPINAL OSTEOARTHRITIS 189
555 BACK DISORDER 188
556 LIP SWELLING 188
557 LABORATORY TEST ABNORMAL 186
558 SOCIAL AVOIDANT BEHAVIOUR 186
559 DISABILITY 185
560 POST PROCEDURAL COMPLICATION 185
561 ABDOMINAL PAIN LOWER 184
562 ARTERIOSCLEROSIS CORONARY ARTERY 184
563 DRUG LEVEL INCREASED 184
564 INITIAL INSOMNIA 184
565 OSTEOMYELITIS 184
566 SCHIZOPHRENIA 184
567 BLOOD UREA INCREASED 183
568 CONTRAINDICATED PRODUCT ADMINISTERED 183
569 THIRST 182
570 URINARY TRACT DISORDER 182
571 ATAXIA 181
572 IMPAIRED GASTRIC EMPTYING 181
573 PRODUCT ADMINISTRATION INTERRUPTED 181
574 SINUS TACHYCARDIA 181
575 LOWER LIMB FRACTURE 180
576 PANIC REACTION 180
577 THYROID DISORDER 180
578 WRIST FRACTURE 180
579 LOSS OF LIBIDO 179
580 COELIAC DISEASE 178
581 INJECTION SITE MASS 178
582 MUSCULOSKELETAL CHEST PAIN 178
583 BLOOD BILIRUBIN INCREASED 177
584 EYE PRURITUS 177
585 INTENTIONAL DRUG MISUSE 177
586 PERICARDIAL EFFUSION 177
587 THERAPEUTIC RESPONSE SHORTENED 177
588 DRUG ADMINISTRATION ERROR 176
589 FAECES DISCOLOURED 176
590 LACRIMATION INCREASED 176
591 CHOKING 175
592 GLAUCOMA 175
593 HYPOKINESIA 175
594 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 174
595 CHROMATURIA 173
596 DEVICE BREAKAGE 172
597 GLOSSODYNIA 172
598 METABOLIC ACIDOSIS 172
599 RED BLOOD CELL SEDIMENTATION RATE INCREASED 171
600 CAESAREAN SECTION 170
601 CARDIOMYOPATHY 170
602 INCONTINENCE 170
603 NEONATAL RESPIRATORY DISTRESS SYNDROME 170
604 PSYCHOLOGICAL TRAUMA 170
605 SCIATICA 170
606 SUBDURAL HAEMATOMA 170
607 PHOTOSENSITIVITY REACTION 169
608 RECALLED PRODUCT ADMINISTERED 169
609 HYPERCHOLESTEROLAEMIA 168
610 ROTATOR CUFF SYNDROME 168
611 IMPAIRED DRIVING ABILITY 167
612 INFARCTION 167
613 KNEE ARTHROPLASTY 167
614 MUSCULOSKELETAL DISCOMFORT 167
615 OSTEONECROSIS 166
616 TOOTH LOSS 166
617 VITAMIN D DEFICIENCY 166
618 CLOSTRIDIUM DIFFICILE INFECTION 165
619 LUNG NEOPLASM MALIGNANT 165
620 RASH GENERALISED 165
621 SOMNAMBULISM 165
622 AMAUROSIS FUGAX 164
623 GAMMA-GLUTAMYLTRANSFERASE INCREASED 164
624 INSURANCE ISSUE 164
625 BLOOD URINE PRESENT 163
626 NODULE 163
627 DISSOCIATION 162
628 NEPHROGENIC ANAEMIA 162
629 POISONING DELIBERATE 162
630 SPINAL FRACTURE 162
631 HERNIA 161
632 LEUKOCYTOSIS 161
633 TEARFULNESS 161
634 VENTRICULAR TACHYCARDIA 161
635 AGEUSIA 160
636 CHOLECYSTECTOMY 160
637 PRURITUS GENERALISED 160
638 MOUTH ULCERATION 159
639 PSORIATIC ARTHROPATHY 159
640 SUICIDAL BEHAVIOUR 159
641 TYPE 1 DIABETES MELLITUS 159
642 BODY HEIGHT DECREASED 158
643 INFUSION SITE PAIN 158
644 JAUNDICE 158
645 POISONING 158
646 DERMATITIS 157
647 AMENORRHOEA 156
648 BLOOD PRESSURE ABNORMAL 154
649 ENCEPHALOPATHY 154
650 TOOTH ABSCESS 153
651 BREATH SOUNDS ABNORMAL 152
652 CORONARY ARTERY OCCLUSION 152
653 LACERATION 152
654 PAIN OF SKIN 151
655 PULMONARY CONGESTION 151
656 PULMONARY MASS 151
657 EMPHYSEMA 150
658 BRAIN FOG 149
659 HEPATIC FAILURE 148
660 HUNGER 148
661 LOCALISED INFECTION 148
662 ASPIRATION 147
663 IMPAIRED QUALITY OF LIFE 147
664 LOCAL SWELLING 147
665 OSTEONECROSIS OF JAW 147
666 PARAESTHESIA ORAL 147
667 FEELING DRUNK 146
668 PHARYNGEAL OEDEMA 146
669 QUALITY OF LIFE DECREASED 146
670 RESPIRATORY TRACT CONGESTION 146
671 FLANK PAIN 145
672 BRADYPHRENIA 144
673 HEMIPARESIS 144
674 HYPOAESTHESIA ORAL 144
675 HYPOMANIA 144
676 INJECTION SITE RASH 144
677 TIC 144
678 CYANOSIS 143
679 NERVE INJURY 143
680 COAGULOPATHY 142
681 SKIN FISSURES 142
682 BACTERIAL INFECTION 141
683 BLOOD POTASSIUM INCREASED 141
684 MELAENA 141
685 PNEUMOTHORAX 141
686 VASCULITIS 141
687 CHOLESTASIS 140
688 DRUG ERUPTION 140
689 DRUG SCREEN FALSE POSITIVE 140
690 DRUG WITHDRAWAL SYNDROME NEONATAL 140
691 INJECTION SITE URTICARIA 140
692 BEDRIDDEN 139
693 GENERALISED TONIC-CLONIC SEIZURE 139
694 IRON DEFICIENCY ANAEMIA 139
695 MALNUTRITION 139
696 NEUROLOGICAL SYMPTOM 139
697 TENDERNESS 139
698 BRAIN INJURY 138
699 NEUTROPHIL COUNT DECREASED 138
700 SELF-INJURIOUS IDEATION 138
701 SLUGGISHNESS 138
702 FEEDING DISORDER 137
703 UPPER GASTROINTESTINAL HAEMORRHAGE 137
704 UTERINE PERFORATION 137
705 VENTRICULAR EXTRASYSTOLES 137
706 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 136
707 GASTROENTERITIS 136
708 HEPATIC CIRRHOSIS 136
709 SKIN LACERATION 136
710 TACHYPHRENIA 136
711 AFFECT LABILITY 135
712 BACK INJURY 135
713 BURSITIS 135
714 CHOLECYSTITIS 135
715 FAILURE TO THRIVE 135
716 NOCTURIA 135
717 ELECTROCARDIOGRAM ABNORMAL 134
718 ORAL DISCOMFORT 134
719 SMALL INTESTINAL OBSTRUCTION 134
720 SYSTEMIC LUPUS ERYTHEMATOSUS 134
721 TOOTH INFECTION 134
722 EYE MOVEMENT DISORDER 133
723 MICTURITION URGENCY 133
724 TOOTH FRACTURE 133
725 VITAMIN D DECREASED 133
726 BLOOD IRON DECREASED 132
727 MOTOR DYSFUNCTION 132
728 MULTIPLE DRUG OVERDOSE 132
729 RENAL FAILURE CHRONIC 132
730 SPLENOMEGALY 132
731 SYNOVITIS 132
732 DIZZINESS POSTURAL 131
733 FULL BLOOD COUNT DECREASED 131
734 MUSCULOSKELETAL DISORDER 131
735 PSYCHOMOTOR SKILLS IMPAIRED 131
736 RASH PAPULAR 131
737 BONE DENSITY DECREASED 130
738 HAIR TEXTURE ABNORMAL 130
739 OESOPHAGITIS 130
740 OVARIAN CYST 130
741 SINUS BRADYCARDIA 130
742 BASAL CELL CARCINOMA 129
743 DIVERTICULUM 129
744 SKIN IRRITATION 129
745 TACHYPNOEA 129
746 WEIGHT FLUCTUATION 129
747 HAIR COLOUR CHANGES 128
748 IMPULSIVE BEHAVIOUR 128
749 LYMPHOCYTE COUNT DECREASED 128
750 MULTI-ORGAN FAILURE 128
751 PANIC DISORDER 128
752 SALIVARY HYPERSECRETION 128
753 BREAST PAIN 127
754 DECREASED ACTIVITY 127
755 FOOT DEFORMITY 127
756 BREAST CANCER FEMALE 126
757 CARDIOVASCULAR DISORDER 126
758 ERUCTATION 126
759 PNEUMONITIS 126
760 ANORGASMIA 125
761 CYST 125
762 DEVELOPMENTAL DELAY 125
763 GLYCOSYLATED HAEMOGLOBIN INCREASED 125
764 HEREDITARY ANGIOEDEMA 125
765 MUSCLE STRAIN 125
766 SELF INJURIOUS BEHAVIOUR 125
767 DRUG PRESCRIBING ERROR 124
768 INFUSION SITE ERYTHEMA 123
769 RENAL CYST 123
770 SUPRAVENTRICULAR TACHYCARDIA 123
771 EXTRA DOSE ADMINISTERED 122
772 RHINITIS ALLERGIC 122
773 SINUS CONGESTION 122
774 BLOOD COUNT ABNORMAL 121
775 CLEFT PALATE 121
776 COLITIS MICROSCOPIC 121
777 DEPRESSION SUICIDAL 121
778 INCORRECT DRUG ADMINISTRATION DURATION 121
779 MYOCARDIAL ISCHAEMIA 121
780 PERIPHERAL COLDNESS 121
781 PLASMA CELL MYELOMA 121
782 STEVENS-JOHNSON SYNDROME 121
783 APPLICATION SITE ERYTHEMA 120
784 CANDIDA INFECTION 120
785 CEREBRAL INFARCTION 120
786 ORAL CANDIDIASIS 120
787 AORTIC VALVE INCOMPETENCE 119
788 TASTE DISORDER 119
789 DEPRESSIVE SYMPTOM 118
790 HEPATIC FUNCTION ABNORMAL 118
791 HYPOTONIA 118
792 LACTIC ACIDOSIS 118
793 LIGAMENT SPRAIN 118
794 MACULAR DEGENERATION 118
795 TOOTH EXTRACTION 118
796 ABSCESS 117
797 COMPLICATION OF DEVICE INSERTION 117
798 FORMICATION 117
799 EJECTION FRACTION DECREASED 116
800 JOINT RANGE OF MOTION DECREASED 116
801 SCRATCH 116
802 CONCUSSION 115
803 HEPATOMEGALY 115
804 ORAL HERPES 115
805 DYSPHORIA 114
806 PRODUCT AVAILABILITY ISSUE 114
807 DYSMENORRHOEA 113
808 HAIR DISORDER 113
809 PHARYNGITIS STREPTOCOCCAL 113
810 DERMATITIS CONTACT 112
811 FACIAL PAIN 112
812 GOUT 112
813 HYPERCALCAEMIA 112
814 HYSTERECTOMY 112
815 LARYNGITIS 112
816 PRODUCT ADMINISTRATION ERROR 112
817 VISUAL DISTURBANCE 112
818 CIRCULATORY COLLAPSE 111
819 DRUG TOLERANCE 111
820 EAR DISCOMFORT 111
821 FLAT AFFECT 111
822 TEMPERATURE INTOLERANCE 111
823 ALCOHOL USE 110
824 FRACTURE 110
825 INCOHERENT 110
826 MULTIPLE ACYL-COENZYME A DEHYDROGENASE DEFICIENCY 110
827 PHARYNGITIS 110
828 SENSATION OF FOREIGN BODY 110
829 TONGUE DISORDER 110
830 FLUID OVERLOAD 109
831 GAMBLING DISORDER 109
832 LUNG INFILTRATION 109
833 MADAROSIS 109
834 TENDONITIS 109
835 VITREOUS FLOATERS 109
836 CONJUNCTIVITIS 108
837 FEELING OF DESPAIR 108
838 GLUCOSE TOLERANCE IMPAIRED 108
839 MUSCLE SPASTICITY 108
840 SNORING 108
841 ENURESIS 107
842 MASS 107
843 NERVE COMPRESSION 107
844 SKIN HAEMORRHAGE 107
845 TRISMUS 107
846 COMPLICATION OF DEVICE REMOVAL 106
847 DEPENDENCE 106
848 EXPIRED PRODUCT ADMINISTERED 106
849 GASTROINTESTINAL PAIN 106
850 HEPATOTOXICITY 106
851 SPINAL DISORDER 106
852 ANAL INCONTINENCE 105
853 BLADDER DISORDER 105
854 BRAIN OEDEMA 105
855 CENTRAL NERVOUS SYSTEM LESION 105
856 CLOSTRIDIUM DIFFICILE COLITIS 105
857 COMPLICATION ASSOCIATED WITH DEVICE 105
858 HYPERTHYROIDISM 105
859 HYPERVENTILATION 105
860 PRODUCT TASTE ABNORMAL 105
861 INCREASED TENDENCY TO BRUISE 104
862 INFUSION SITE SWELLING 104
863 NO THERAPEUTIC RESPONSE 104
864 PULMONARY ALVEOLAR HAEMORRHAGE 104
865 SCREAMING 104
866 BLOOD PRESSURE DIASTOLIC DECREASED 103
867 BRADYKINESIA 103
868 EXOSTOSIS 103
869 FAECAL INCONTINENCE 103
870 GESTATIONAL DIABETES 103
871 JOINT DISLOCATION 103
872 SHOCK 103
873 TUBULOINTERSTITIAL NEPHRITIS 103
874 ALCOHOLISM 102
875 MULTIPLE ALLERGIES 102
876 PARALYSIS 102
877 BLOOD PROLACTIN INCREASED 101
878 DECUBITUS ULCER 101
879 DIABETIC COMA 101
880 ELECTROLYTE IMBALANCE 101
881 INJECTION SITE HAEMATOMA 101
882 SKIN CANCER 101
883 BLOOD CALCIUM DECREASED 100
884 BLOOD MAGNESIUM DECREASED 100
885 HIP ARTHROPLASTY 100
886 ISCHAEMIC STROKE 100
887 LUNG INFECTION 100
888 NEOPLASM PROGRESSION 100
889 NEURITIS 100
890 PLATELET COUNT INCREASED 100
891 PRODUCT DISPENSING ERROR 100
892 ACCIDENT 99
893 FACE OEDEMA 99
894 FORCED EXPIRATORY VOLUME DECREASED 99
895 PRODUCT ADHESION ISSUE 99
896 AGRANULOCYTOSIS 98
897 BODY TEMPERATURE DECREASED 98
898 DEVICE LEAKAGE 98
899 DRUG DISPENSING ERROR 98
900 HYPERAESTHESIA 98
901 MULTIPLE FRACTURES 98
902 NEEDLE ISSUE 98
903 RHEUMATOID FACTOR POSITIVE 98
904 SCOLIOSIS 98
905 DEVICE DIFFICULT TO USE 97
906 GALACTORRHOEA 97
907 NORMOCHROMIC NORMOCYTIC ANAEMIA 97
908 OVERWEIGHT 97
909 RESPIRATORY DEPRESSION 97
910 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 97
911 IMMUNE SYSTEM DISORDER 96
912 LOSS OF EMPLOYMENT 96
913 STOMACH DISCOMFORT 96
914 DYSPHEMIA 95
915 HYPOMAGNESAEMIA 95
916 LEFT VENTRICULAR HYPERTROPHY 95
917 PERSONALITY DISORDER 95
918 PRODUCT PRESCRIBING ERROR 95
919 REFUSAL OF TREATMENT BY PATIENT 95
920 SPINAL COMPRESSION FRACTURE 95
921 ANGINA UNSTABLE 94
922 BLINDNESS UNILATERAL 94
923 HEPATITIS C 94
924 MUSCLE ATROPHY 94
925 MUSCLE DISORDER 94
926 RESPIRATORY SYMPTOM 94
927 ANXIETY DISORDER 93
928 HOSTILITY 93
929 PHOBIA 93
930 SKIN WARM 93
931 TRANSAMINASES INCREASED 93
932 VENTRICULAR FIBRILLATION 93
933 PSYCHIATRIC DECOMPENSATION 92
934 UPPER-AIRWAY COUGH SYNDROME 92
935 VAGINAL DISCHARGE 92
936 ACUTE RESPIRATORY DISTRESS SYNDROME 91
937 DRY THROAT 91
938 HYPERPHAGIA 91
939 PRODUCT USE COMPLAINT 91
940 PULMONARY VASCULITIS 91
941 BIPOLAR I DISORDER 90
942 LOW DENSITY LIPOPROTEIN INCREASED 90
943 METABOLIC DISORDER 90
944 SECRETION DISCHARGE 90
945 UTERINE LEIOMYOMA 90
946 ANAPHYLACTIC SHOCK 89
947 DEVICE RELATED INFECTION 89
948 HEARING IMPAIRED 89
949 HEPATIC CYTOLYSIS 89
950 MENSTRUAL DISORDER 89
951 POLYURIA 89
952 PRE-ECLAMPSIA 89
953 TRANSPOSITION OF THE GREAT VESSELS 89
954 APHONIA 88
955 DROOLING 88
956 ESSENTIAL HYPERTENSION 88
957 HYPERACUSIS 88
958 HYPERREFLEXIA 88
959 JAW DISORDER 88
960 RESPIRATORY RATE INCREASED 88
961 APNOEA 87
962 BUNDLE BRANCH BLOCK RIGHT 87
963 ENERGY INCREASED 87
964 LARGE INTESTINE POLYP 87
965 OBSESSIVE THOUGHTS 87
966 PELVIC FRACTURE 87
967 SPINAL COLUMN STENOSIS 87
968 CONJUNCTIVITIS ALLERGIC 86
969 DYSLIPIDAEMIA 86
970 ECCHYMOSIS 86
971 HYPOCALCAEMIA 86
972 MIOSIS 86
973 RASH MACULO-PAPULAR 86
974 SENSORY LOSS 86
975 SINUS HEADACHE 86
976 SPINAL PAIN 86
977 SUBSTANCE ABUSE 86
978 VENTRICULAR HYPERTROPHY 86
979 DYSGRAPHIA 85
980 ELECTRIC SHOCK SENSATION 85
981 HOSPICE CARE 85
982 HYPERPARATHYROIDISM SECONDARY 85
983 APPLICATION SITE PRURITUS 84
984 BLOOD CHOLESTEROL ABNORMAL 84
985 DIFFICULTY IN WALKING 84
986 DRUG ABUSER 84
987 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 84
988 MUCOSAL INFLAMMATION 84
989 OTITIS MEDIA 84
990 PERIPHERAL VASCULAR DISORDER 84
991 PETECHIAE 84
992 POST PROCEDURAL HAEMORRHAGE 84
993 PREMATURE LABOUR 84
994 RHINITIS 84
995 UNINTENDED PREGNANCY 84
996 YAWNING 84
997 BILIARY DYSKINESIA 83
998 CANDIDIASIS 83
999 DILATATION VENTRICULAR 83